PT2454364E - Produção de poliovírus com elevados títulos para produção de vacina - Google Patents
Produção de poliovírus com elevados títulos para produção de vacina Download PDFInfo
- Publication number
- PT2454364E PT2454364E PT107298952T PT10729895T PT2454364E PT 2454364 E PT2454364 E PT 2454364E PT 107298952 T PT107298952 T PT 107298952T PT 10729895 T PT10729895 T PT 10729895T PT 2454364 E PT2454364 E PT 2454364E
- Authority
- PT
- Portugal
- Prior art keywords
- production
- high titers
- polio virus
- vaccine
- vaccine production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32651—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27103809P | 2009-07-16 | 2009-07-16 | |
EP09165620 | 2009-07-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2454364E true PT2454364E (pt) | 2014-07-04 |
Family
ID=41412431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT107298952T PT2454364E (pt) | 2009-07-16 | 2010-07-08 | Produção de poliovírus com elevados títulos para produção de vacina |
Country Status (33)
Country | Link |
---|---|
US (4) | US8546123B2 (pt) |
EP (1) | EP2454364B1 (pt) |
JP (1) | JP5845178B2 (pt) |
KR (1) | KR101548790B1 (pt) |
CN (1) | CN102482647B (pt) |
AP (1) | AP3140A (pt) |
AR (1) | AR077314A1 (pt) |
AU (1) | AU2010272685B2 (pt) |
BR (1) | BR112012000942B8 (pt) |
CA (1) | CA2763091C (pt) |
CO (1) | CO6491042A2 (pt) |
CU (1) | CU20120006A7 (pt) |
DK (1) | DK2454364T3 (pt) |
EA (1) | EA020563B1 (pt) |
ES (1) | ES2484093T3 (pt) |
HK (1) | HK1164922A1 (pt) |
HR (1) | HRP20140597T1 (pt) |
IL (1) | IL217465A (pt) |
MA (1) | MA33429B1 (pt) |
MX (1) | MX2011012648A (pt) |
MY (1) | MY183385A (pt) |
NZ (1) | NZ596880A (pt) |
PE (1) | PE20120571A1 (pt) |
PL (1) | PL2454364T3 (pt) |
PT (1) | PT2454364E (pt) |
RS (1) | RS53377B (pt) |
SG (1) | SG177655A1 (pt) |
SI (1) | SI2454364T1 (pt) |
SM (1) | SMT201400079B (pt) |
TN (1) | TN2011000628A1 (pt) |
TW (1) | TWI477606B (pt) |
WO (1) | WO2011006823A1 (pt) |
ZA (1) | ZA201108271B (pt) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2007245192B2 (en) | 2006-03-31 | 2012-04-12 | Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses for vaccines |
WO2008156778A2 (en) | 2007-06-18 | 2008-12-24 | Tokiko Watanabe | Influenza m2 protein mutant viruses as live influenza attenuated vaccines |
ES2532015T3 (es) | 2008-11-03 | 2015-03-23 | Crucell Holland B.V. | Método para la producción de vectores adenovíricos |
KR101548790B1 (ko) | 2009-07-16 | 2015-08-31 | 크루셀 홀란드 비.브이. | 백신 제조를 위한 고역가 폴리오바이러스의 제조 |
US9109013B2 (en) | 2009-10-26 | 2015-08-18 | Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses with enhanced replication in vero cells |
US10130697B2 (en) | 2010-03-23 | 2018-11-20 | Wisconsin Alumni Research Foundation (Warf) | Vaccines comprising mutant attenuated influenza viruses |
CN105121645B (zh) | 2013-02-05 | 2018-05-08 | 乔治亚大学研究基金公司 | 用于病毒生产的细胞系和使用方法 |
PE20151720A1 (es) | 2013-03-08 | 2015-12-10 | Crucell Holland Bv | Vacuna acelular contra pertussis |
CN105121634B (zh) | 2013-03-13 | 2019-07-26 | 易木农麦克斯有限公司 | 具有提高的病毒生产能力的细胞系及其生产方法 |
KR20140112255A (ko) | 2013-03-13 | 2014-09-23 | 고려대학교 산학협력단 | 바이러스 생산능이 증가된 세포주 및 그 제조방법 |
GB201305361D0 (en) | 2013-03-25 | 2013-05-08 | Univ Edinburgh | Enhanced expression |
EP3010537B1 (en) | 2013-06-17 | 2018-07-11 | De Staat der Nederlanden, vert. door de minister Van VWS, Ministerie van Volksgezondheid, Welzijn en Sport | Methods for the prevention of aggregation of viral components |
JP2016524915A (ja) | 2013-07-15 | 2016-08-22 | ウィスコンシン アルムニ リサーチ ファンデイション | Mdck、ベロ細胞又は卵内で増強された複製を有する高力価の組換えインフルエンザウイルス |
US20160053281A1 (en) * | 2013-08-15 | 2016-02-25 | The University Court Of The University Of Edinburgh | Enhanced Expression Of RNA Vectors |
US11008547B2 (en) | 2014-03-25 | 2021-05-18 | Terumo Bct, Inc. | Passive replacement of media |
BR112016028936A2 (pt) | 2014-06-17 | 2017-10-31 | Janssen Vaccines & Prevention Bv | atenuação viral adaptada ao frio (cava) e cepas de poliovírus atenuadas inovadoras |
US10526393B2 (en) | 2014-06-18 | 2020-01-07 | Immunomax Co., Ltd. | Method for promoting virus infection and increasing virus production, by using cell line having lost BST2 gene functions |
US10053671B2 (en) | 2014-06-20 | 2018-08-21 | Wisconsin Alumni Research Foundation (Warf) | Mutations that confer genetic stability to additional genes in influenza viruses |
KR102364111B1 (ko) | 2014-07-24 | 2022-02-17 | 얀센 백신스 앤드 프리벤션 비.브이. | 세포 배양물로부터 폴리오바이러스의 정제 방법 |
US10633422B2 (en) | 2015-06-01 | 2020-04-28 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA |
WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
US9890363B2 (en) | 2015-07-06 | 2018-02-13 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication for vaccine development |
WO2017143236A1 (en) | 2016-02-19 | 2017-08-24 | Yoshihiro Kawaoka | Improved influenza b virus replication for vaccine development |
JP7034949B2 (ja) | 2016-05-25 | 2022-03-14 | テルモ ビーシーティー、インコーポレーテッド | 細胞の増殖 |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
US10372100B2 (en) * | 2016-08-29 | 2019-08-06 | Ge Healthcare Bio-Sciences Corp. | Manufacturing system for biopharmaceutical products |
JP7393945B2 (ja) | 2017-03-31 | 2023-12-07 | テルモ ビーシーティー、インコーポレーテッド | 細胞増殖 |
CN107723279B (zh) * | 2017-10-18 | 2020-11-10 | 成都远睿生物技术有限公司 | 一种缺陷型腺病毒AdC68-GP的培养方法 |
EP3749757A4 (en) * | 2018-02-07 | 2021-11-24 | Bharat Biotech International Limited | PROCEDURES FOR ENTEROVIRUS CLEANING AND INACTIVATION AND VACCINE COMPOSITIONS RESULTED FROM THEM |
WO2020167432A2 (en) | 2019-01-23 | 2020-08-20 | Yoshihiro Kawaoka | Mutations that confer genetic stability to additional genes in influenza viruses |
US11851648B2 (en) | 2019-02-08 | 2023-12-26 | Wisconsin Alumni Research Foundation (Warf) | Humanized cell line |
WO2020223699A1 (en) | 2019-05-01 | 2020-11-05 | Wisconsin Alumni Research Foundation (Warf) | Improved influenza virus replication for vaccine development |
EP3969046A1 (en) | 2019-05-16 | 2022-03-23 | Janssen Vaccines & Prevention B.V. | Methods for inducing a safe immune response against polio virus |
US11807872B2 (en) | 2019-08-27 | 2023-11-07 | Wisconsin Alumni Research Foundation (Warf) | Recombinant influenza viruses with stabilized HA for replication in eggs |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4525349A (en) | 1981-12-29 | 1985-06-25 | Societe Anonyme Dite: Institut Merueux | Process for the large-scale production of a vaccine against poliomyelitis and the resulting vaccine |
PT1445322E (pt) | 1995-06-15 | 2010-01-19 | Crucell Holland Bv | Sistemas de empacotamento para adenovírus recombinante humano destinados a terapia genética |
US7521220B2 (en) | 1999-11-26 | 2009-04-21 | Crucell Holland B.V. | Production of vaccines |
EP1103610A1 (en) * | 1999-11-26 | 2001-05-30 | Introgene B.V. | Production of vaccines from immortalised mammalian cell lines |
US6544424B1 (en) | 1999-12-03 | 2003-04-08 | Refined Technology Company | Fluid filtration system |
EP1256803A1 (en) | 2001-05-07 | 2002-11-13 | Crucell Holland B.V. | Methods for the identification of antiviral compounds |
AU2003288273A1 (en) | 2002-10-23 | 2004-05-13 | Crucell Holland B.V. | New settings for recombinant adenoviral-based vaccines |
WO2004055187A1 (en) | 2002-12-17 | 2004-07-01 | Crucell Holland B.V. | Recombinant viral-based malaria vaccines |
CA2520891C (en) | 2003-05-09 | 2014-07-08 | Crucell Holland B.V. | Cultures of e1-immortalized cells and processes for culturing the same to increase product yields therefrom |
EP1720972B1 (en) | 2004-03-05 | 2014-01-08 | DSM IP Assets B.V. | Process for cell culturing by continuous perfusion and alternating tangential flow |
BRPI0419023A (pt) | 2004-08-27 | 2007-12-11 | Panacea Biotec Ltd | vacina contra poliomielite inativada e derivada do genero sabin de vìrus da polio |
ES2371175T3 (es) | 2004-10-14 | 2011-12-28 | Crucell Holland B.V. | Vacunas de sensibilización/refuerzo de malaria. |
CN100500827C (zh) * | 2004-11-26 | 2009-06-17 | 中国医学科学院医学生物学研究所 | 用人胚肺二倍体细胞培养繁殖脊髓灰质炎病毒的方法 |
US20100144620A1 (en) | 2006-11-16 | 2010-06-10 | Crucell Holland B.V. | Complementation of factor xi deficeincy by factor v mutants |
KR101548790B1 (ko) | 2009-07-16 | 2015-08-31 | 크루셀 홀란드 비.브이. | 백신 제조를 위한 고역가 폴리오바이러스의 제조 |
KR20120070015A (ko) | 2010-12-21 | 2012-06-29 | (주)창조바이오텍 | 알파-피넨을 유효성분으로 포함하는 스쿠티카충 구제용 조성물 |
-
2010
- 2010-07-08 KR KR1020127001501A patent/KR101548790B1/ko active IP Right Grant
- 2010-07-08 PL PL10729895T patent/PL2454364T3/pl unknown
- 2010-07-08 EP EP10729895.2A patent/EP2454364B1/en active Active
- 2010-07-08 CN CN201080026814.2A patent/CN102482647B/zh active Active
- 2010-07-08 PE PE2012000051A patent/PE20120571A1/es active IP Right Grant
- 2010-07-08 EA EA201270173A patent/EA020563B1/ru not_active IP Right Cessation
- 2010-07-08 AU AU2010272685A patent/AU2010272685B2/en not_active Ceased
- 2010-07-08 DK DK10729895.2T patent/DK2454364T3/da active
- 2010-07-08 ES ES10729895.2T patent/ES2484093T3/es active Active
- 2010-07-08 PT PT107298952T patent/PT2454364E/pt unknown
- 2010-07-08 CA CA2763091A patent/CA2763091C/en active Active
- 2010-07-08 BR BR112012000942A patent/BR112012000942B8/pt not_active IP Right Cessation
- 2010-07-08 MY MYPI2012000173A patent/MY183385A/en unknown
- 2010-07-08 RS RS20140325A patent/RS53377B/en unknown
- 2010-07-08 MA MA34534A patent/MA33429B1/fr unknown
- 2010-07-08 SG SG2012002705A patent/SG177655A1/en unknown
- 2010-07-08 MX MX2011012648A patent/MX2011012648A/es active IP Right Grant
- 2010-07-08 WO PCT/EP2010/059796 patent/WO2011006823A1/en active Application Filing
- 2010-07-08 SI SI201030661T patent/SI2454364T1/sl unknown
- 2010-07-08 AP AP2012006075A patent/AP3140A/xx active
- 2010-07-08 JP JP2012519981A patent/JP5845178B2/ja active Active
- 2010-07-08 NZ NZ596880A patent/NZ596880A/xx not_active IP Right Cessation
- 2010-07-14 AR ARP100102556A patent/AR077314A1/es active IP Right Grant
- 2010-07-15 TW TW099123327A patent/TWI477606B/zh not_active IP Right Cessation
- 2010-07-16 US US12/804,242 patent/US8546123B2/en active Active
-
2011
- 2011-11-10 ZA ZA2011/08271A patent/ZA201108271B/en unknown
- 2011-12-07 TN TNP2011000628A patent/TN2011000628A1/en unknown
-
2012
- 2012-01-10 IL IL217465A patent/IL217465A/en active IP Right Grant
- 2012-01-13 CU CU2012000006A patent/CU20120006A7/es unknown
- 2012-01-16 CO CO12005515A patent/CO6491042A2/es unknown
- 2012-05-31 HK HK12105337.7A patent/HK1164922A1/xx not_active IP Right Cessation
- 2012-10-25 US US13/660,412 patent/US20130052224A1/en not_active Abandoned
-
2013
- 2013-03-15 US US13/843,052 patent/US20130273106A1/en not_active Abandoned
-
2014
- 2014-05-12 US US14/275,392 patent/US9022240B2/en active Active
- 2014-06-24 SM SM201400079T patent/SMT201400079B/xx unknown
- 2014-06-26 HR HRP20140597AT patent/HRP20140597T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP3140A (en) | Production of polio virus at high titers for vaccine production | |
IL270661B (en) | A method for preparing vlps that are plant histories | |
HUS1700002I1 (hu) | Hepatitis C vírus replikációjának inhibitorai | |
HK1178165A1 (en) | Novel inhibitors of hepatitis virus replication | |
EP2470189A4 (en) | METHODS FOR PREPARING HEPATITIS C VIRUS PROTEASE INHIBITORS | |
ZA201202758B (en) | Stabilising excipient for inactivated whole-virus vaccines | |
HK1166704A1 (zh) | 利用用於鼻內給藥的疫苗預防流感的方法 | |
EP2484378A4 (en) | VACCINE COMPOSITION AGAINST HEPATITIS C VIRUS | |
PL2396032T3 (pl) | Szczepionki przeciw grypie o obniżonych zawartościach skwalenu | |
ZA201101645B (en) | Process for prodcution of vaccines | |
GB0918679D0 (en) | Influenza vaccine | |
EP2482843A4 (en) | PROCESS FOR IMPROVED VACCINE IMMUNOGENICITY | |
EP2484757A4 (en) | VIRUS FOR THE EXPRESSION OF ALPHA GALACTOSE EPITOPES AND METHOD FOR THE PRODUCTION OF A VACCINE | |
GB2467215B (en) | Burkholderia components vaccine | |
EP2432885A4 (en) | METHOD FOR INCREASING THE INFECTIOUSITY OF RETROVIRUSES | |
EP2424879A4 (en) | INFLUENZA VACCINE | |
EP2488185A4 (en) | INFECTIOUS TORQUE TENO VIRUS CLONE | |
HK1177692A1 (zh) | 新的流感病毒 | |
GB0714489D0 (en) | Process for preparing viral vaccine | |
ZA201203862B (en) | Dna vaccine against virus of yellow fever | |
GB0920319D0 (en) | HPV vaccine | |
GB0903910D0 (en) | Vaccine production |